Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “METARAMINOL”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 73 records · Page 4Linked to original sources

[The metaraminol provocation test in the diagnosis of familial Mediterranean fever].

Familial Mediterranean Fever (FMF) is a cyclic inflammatory disease of unknown pathogenesis and autosomal recessive inheritance. Diagnosis is notoriously difficult by the lack of specific signs or laboratory tests although early diagnosis is mandatory to avoid developmental delay or possibly fatal amyloidosis by treatment with colchicine. In adults, Metaraminol Provocative Test (MPT) has been described as specific and highly sensitive in the diagnoses of FMF. We tested 18 children, 9 of whom suffered from FMF. They were ill for 5 years and had been treated as in-patients for 3 months without improvement (median values). 5 of the children with FMF had a positive test results. 4 children with FMF were negative. All 9 children with other disorders were negative, too. During the course of diagnosis, they had been suspected of suffering from FMF. So, in childhood, MPT is specific for FMF but does not identify all children with FMF. However, a positive MPT may be a great help in diagnosing FMF.

Child↗

[Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)].

The present experiments were undertaken in investigate the effects of Ro4-4602 plus L-Dopa on biphasic action induced by metaraminol (MA) in mice. The following results were obtained: Spontaneous motor activity (SMA) suppressed by MA was recovered by pretreatment of Ro4-4602 plus L-Dopa and increased by more than 100 mg/kg of L-Dopa. However, SMA was increased by more than 400 mg/kg of L-Dopa in saline pretreated mice. In MA pretreated mice, SMA by L-Dopa markedly increased in proportion to the doses of MA. The peak time of SMA by L-Dopa in MA pretreated mice was observed to be faster than that in saline pretreated mice. When L-Dopa was injected into MA and saline pretreated mice, there was no significant difference of brain dopamine content between the two groups. From the above results, it is considered that the enhanced effect of L-Dopa in MA pretreated mice may be due to production of a supersensitivity to catecholamines in the central nervous system. MA induced hyper-motor activity was enhanced by pretreatment of Ro4-4602 plus L-Dopa which have no influence on SMA.

Animals↗

[Central action of beta-phenylethylamine derivatives (9). Effects of intracerebral administration of metaraminol on brain monoamine in mice (author's transl)].

Effects of intracerebral (i.c.) administration of metaraminol (MA) on brain monoamine in mice were studied. The results were as follows: MA, dopamine (DA), noradrenaline (NA) and 5-hydroxytryptamine (5-HT) were separated with phosphate buffer using a phosphorylated cellulose column (1X11 cm, 9 ml, Lot No. 2809). When MA was i.c. injected into mice, fluorescence of MA at 275/305 nm decreased in proportion to the time course and remained even at 12 hr after injection. Thirty min after MA in doses of either 40 or 80 microgram, a significant decrease of DA as compared with that of saline-treated group occurred and MA, in doses of 40, 80 and 160 microgram produced a significant decrease of NA and 5-HT. Thirty min after 160 microgram of MA, there was no significant difference in DA. Three hr after MA, DA levels significantly decreased, and 168 hr after were restored to the levels of the saline-treated group. Thirty min after MA, NA and 5-HT signficantly decreased compared with those of the saline-treated group and recovery took place 48 hr and 168 hr after respectively. It was concluded that MA depletes not only NA but also DA and 5-HT in the mouse brain.

Animals↗